Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Califf: Sponsors Should Go Beyond Letter Of Law With Trial Diversity Plans
Nov 22 2024
•
By
Sarah Karlin-Smith
FDA Commissioner Robert Califf said trial diversity will improve through analysis of trial diversity plans.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Diversity & Inclusion
More from R&D